News Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:35:28 2025-06-18 am EDT			5-day change	1st Jan Change
27.20 ^EUR	+0.17%		-1.98%	+40.86%

Jun. 17	Bayer Files for FDA Approval of Gadoquatrane	DJ
Jun. 17	Bayer Seeks US FDA Nod for MRI Contrast Agent Gadoquatrane	MT

Bayer Files for FDA Approval of Gadoquatrane	Jun. 17	DJ
Bayer Innovation Procurement Expands Use of Scientist.com's AI-Powered Platform for Global R&D Procurement Orchestration	Jun. 17	AQ
Bayer Seeks US FDA Nod for MRI Contrast Agent Gadoquatrane	Jun. 17	MT
Bayer Files For Approval Of Gadoquatrane In The U.S	Jun. 17	RE
Bayer : files for approval of gadoquatrane in the U.S.	Jun. 17	PU
Bayer Files For Approval Of Gadoquatrane In U.S.	Jun. 17	RE
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 12	EQ
DAX Opens Slightly Higher as China and US Ease Export Restrictions	Jun. 12	RE
HSBC Upgrades Bayer to Buy, Boosts PT	Jun. 11	MT
Bayer at annual high after two buy recommendations	Jun. 11	DP
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies	Jun. 11	CI
Bayer strong in pre-market trading after two buy recommendations	Jun. 11	DP
Bayer extends partnership with Broad Institute	Jun. 11	CF
Frankfurt stock market opening: Dax stable after three weaker days	Jun. 11	DP
BAYER : Potatoes may become a precious commodity	Jun. 10
European shares inch up as Lagarde's remarks offset ECB rate cut	Jun. 05	RE
German Stocks Close Higher as ECB Cuts Rates Again	Jun. 05	MT
Bayer Aktiengesellschaft Presents at 2025 dbAccess Global Consumer Conference, Jun-05-2025 08:30 AM	Jun. 05
Bayer, close to the final round(up)?	Jun. 05
Bayer: promising results in diabetic kidney disease	Jun. 05	CF
Goldman Sachs Upgrades Bayer to Buy, Raises PT	Jun. 05	MT
Bayer: shares rise, on Goldman Sachs' upgrade	Jun. 05	CF
Bayer's Trial Shows Improved Kidney Outcomes With Finerenone-Empagliflozin Combo	Jun. 05	MT
Bayer : Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes	Jun. 05	PU
Simultaneous Treatment Start With Finerenone And SGLT-2-Inhibitor Demonstrated Positive Data	Jun. 05	RE